Global Nuclear Medicine Radiopharmaceuticals Market is anticipated to reach US$ 8.44 Bn by 2020

According to the report "Nuclear Medicine Radiopharmaceuticals Market", published by Market Data Forecast, the global market is projected to reach USD 8.44 billion by 2020, at a CAGR of 13.4% from 2015 to 2020.

For full report refer to http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-radiopharmaceuticals-market-130/

Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease. Radiopharmaceuticals target a specific organ or site and emit the gamma radiations. These radiopharmaceuticals are administered inside the body by different routes of administration such as oral, inhalation or injection depending on the drug and targeted organ

Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-radiopharmaceuticals-market-130/request-sample

Increasing prevalence of cancer and cardiac ailments, massive technological advancements, growing demand for SPECT and PET applications along with the increasing public awareness for healthcare are the major factors fuelling the market growth for Radiopharmaceuticals. Further, Integration of X ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a powerful factor for the growth of the market. However short half-life of radiopharmaceuticals and strict regulatory framework for pose a great threat to the market growth. Reimbursement also is a major factor restraining the growth of the market.

Global Nuclear Medicine Radiopharmaceuticals market is segmented by type and Application. By type it is further classified as diagnostic radioisotopes and therapeutic radioisotopes

1) Diagnostic Radioisotopes
a) SPECT
• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-23
• Others

b) PET
• Fluorine-18
• Rubidium-82
• Others

2) Therapeutic Radio Isotopes
a) Beta Emitters
• Iodine-131
• Yttrium-90
• Samarium-153
• Rhenium-186
• Lutetium-177

b) Alpha Emitters
• Radium-223

c) Brachytherapy
• Cesium-131
• Iodine-125
• Palladium-103
• Iridium-192

By Application
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Oncology
• Others

Some of the major players covered in the report are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

About Market Data Forecast:

Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact Us:

Market Data Forecast, Inc.
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com

This release was published on openPR.